期刊文献+

西妥昔单抗联合化疗治疗晚期结直肠癌的护理 被引量:4

下载PDF
导出
摘要 目的探讨西妥昔单抗联合化疗治疗晚期结直肠癌的护理。方法对18例晚期结直肠癌患者应用西妥昔单抗联合化疗,化疗期间重点做好西妥昔单抗不良反应的预防及护理,减轻不良反应的发生。结果治疗过程中未出现因西妥昔单抗引起的严重不良反应而影响治疗,所有患者均顺利完成治疗。结论精心护理可预防和减轻西妥昔单抗不良反应的发生,保障治疗的顺利进行,提高治疗效果。
出处 《解放军护理杂志》 2007年第12B期61-62,共2页 Nursing Journal of Chinese People's Liberation Army
  • 相关文献

参考文献8

二级参考文献32

  • 1孔秋焕,邹本燕,刘晓华.美罗华治疗B细胞淋巴瘤并发症的护理[J].现代护理,2004,10(8):725-726. 被引量:9
  • 2Bienvenu J, Chvetzoff R,Salles G, et al. Tumor necrosis factor alpha release is a major biological event associated with rituximab treat- ment[J]. Hematol J,2001,2(6):378-384
  • 3Raymond E, Faivre S, Armand JP. Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy [ J ]. Drugs, 2000,60(Suppl 1) :S15 - S23.
  • 4Baselga J. The EGFR as a target for anticancer therapy-focus on cetuximab [ J ] . Eur J Cancer, 2001,37 ( Suppl 4) : S16 - S22.
  • 5Kim ES, Khuri FR, Herbst RS. Epidermal growth factor receptor biology(1MC-C225) [J].Curr Opin Oncol,2001,13(6) : 506 - 513.
  • 6Ciardiello F, Tortora G. Anti-epidermal growth factor receptor drugs in cancer therapy [ J ]. Expert Opin Investig Drugs, 2002, 11 (6) : 755 -768.
  • 7Prewett MC, Hooper AT, Bassi R, et al. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11)against human colorectal tumor xenografts [ J ]. Clin Cancer Res, 2002,8 ( 5 ) : 994 -1003.
  • 8Bianco C, Bianco R,Tortora G, et al. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide [ J ]. Clin Cancer Res,2000,6( 11 ) :4343 - 4350.
  • 9Folprecht G, Lutz MP, Schoeffski P, et al. Pharmacokinetic ( PK )evaluation of cetuximab in combination with weekly irinotecan( CPT-11 )and 24h infusional 5-FU/folinic acid(FA)as first line treatment in patients(pts) with epidermal growth factor receptor ( EGFR)-positive metastatic colorectal cancer(MCRC) [J]. Proc Am Soc Clin Oncol ,2003,22 (2) : 222.
  • 10Baselga J, Pfister D, Cooper MR, et al. Phase I studies of antiepidermal growth factor receptor chimeric antibody C225 alone and incombination with cisplatin [ J ]. J Clin Oncol , 2000,18 ( 4 ) : 904 -914.

共引文献60

同被引文献26

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部